Cargando…

Hyperphosphatemia is not significantly associated with increased all-cause mortality in Korean hemodialysis patients

Detalles Bibliográficos
Autores principales:	Wakasugi, Minako, Sakaguchi, Yusuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Nephrology 2018
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312770/ https://www.ncbi.nlm.nih.gov/pubmed/30619699 http://dx.doi.org/10.23876/j.krcp.18.0129

Ejemplares similares

Magnesium Modifies the Cardiovascular Mortality Risk Associated with Hyperphosphatemia in Patients Undergoing Hemodialysis: A Cohort Study
por: Sakaguchi, Yusuke, et al.
Publicado: (2014)

Letter Regarding “Dose-Response of Tenapanor in Patients With Hyperphosphatemia Undergoing Hemodialysis in Japan—A Phase 2 Randomized Trial”
por: Aoki, Yuki, et al.
Publicado: (2022)

In Reply to “Letter Regarding ‘Dose-Response of Tenapanor in Patients With Hyperphosphatemia Undergoing Hemodialysis in Japan—A Phase 2 Randomized Trial’”
por: Inaba, Masaaki, et al.
Publicado: (2022)

Non-occlusive Mesenteric Ischemia with Significant Hyperphosphatemia
por: Yamada, Aki, et al.
Publicado: (2022)

Both hypophosphatemia and hyperphosphatemia are associated with increased mortality in septic patients
por: Liu, Zheng, et al.
Publicado: (2022)

Safety and efficacy of nicotinamide in the management of hyperphosphatemia in patients on hemodialysis
por: Vasantha, J., et al.
Publicado: (2011)

Hyperphosphatemia is associated with high mortality in severe burns
por: Kuo, George, et al.
Publicado: (2018)

Increased Proton Pump Inhibitors−Induced Mortality Risk in Hemodialysis Patients
por: Sertorio, Jonas T., et al.
Publicado: (2018)

NaPi-IIb Inhibition for Hyperphosphatemia in CKD Hemodialysis Patients
por: Maruyama, Sonomi, et al.
Publicado: (2020)

Intensified treatment of hyperphosphatemia associated with reduction in parathyroid hormone in patients on maintenance hemodialysis
por: Chen, Lan, et al.
Publicado: (2018)

Hyperphosphatemia is associated with patency loss of arteriovenous fistula after 1 year of hemodialysis
por: Moon, Ju-Young, et al.
Publicado: (2015)

Sex Differences in Cause-specific Mortality in Japanese Dialysis Patients
por: Wakasugi, Minako, et al.
Publicado: (2022)

Significant Effect of Raloxifene on Bone in Hemodialysis Patients
por: Ravn, Pernille
Publicado: (2012)

Sevelamer carbonate in the treatment of hyperphosphatemia in patients with chronic kidney disease on hemodialysis
por: Savica, Vincenzo, et al.
Publicado: (2008)

Meta-analysis of the efficacy and safety of sevelamer as hyperphosphatemia therapy for hemodialysis patients
por: Zeng, Qian, et al.
Publicado: (2023)

Excess All-Cause Mortality During the COVID-19 Outbreak in Japan
por: Yorifuji, Takashi, et al.
Publicado: (2021)

Low calcium dialysate combined with CaCO(3) in hyperphosphatemia in hemodialysis patients
por: GAO, ZHUO, et al.
Publicado: (2013)

Calcium Acetate or Calcium Carbonate for Hyperphosphatemia of Hemodialysis Patients: A Meta-Analysis
por: Wang, Yong, et al.
Publicado: (2015)

Efficacy of crushed lanthanum carbonate for hyperphosphatemia in hemodialysis patients undergoing tube feeding
por: Kitajima, Yukie, et al.
Publicado: (2011)

Comment on: “Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Mode”
por: Rascati, Karen
Publicado: (2017)

All-cause and cause-specific mortality associated with diabetes in prevalent hemodialysis patients
por: Sattar, Abdus, et al.
Publicado: (2012)

COVID-19 deaths in children: comparison with all- and other causes and trends in incidence of mortality
por: Bhopal, S.S., et al.
Publicado: (2020)

Letter to the editor: COVID-19 and all-cause excess mortality in Iran in spring 2020
por: Tadbiri, Hooman, et al.
Publicado: (2020)

Letter to the Editor: Potent Anticoagulants Are Associated with a Higher All-cause Mortality Rate After Hip and Knee Arthroplasty
por: Eriksson, Bengt I., et al.
Publicado: (2008)

Statins and All‐Cause Mortality in Patients Undergoing Hemodialysis
por: Jung, Jaehun, et al.
Publicado: (2020)

The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia
por: Block, Geoffrey A, et al.
Publicado: (2019)

Hemodialysis catheter-related bacteremia caused by Stenotrophomonas maltophilia
por: Kataria, A., et al.
Publicado: (2015)

Reply to Letter to Editor: Potent Anticoagulants are Associated with a Higher All-cause Mortality Rate after Hip and Knee Arthroplasty
por: Sharrock, Nigel E., et al.
Publicado: (2008)

Hyperphosphatemia and Cardiovascular Disease
por: Zhou, Chao, et al.
Publicado: (2021)

Hidden Hypocalcemia as a Risk Factor for Cardiovascular Events and All-Cause Mortality among Patients Undergoing Incident Hemodialysis
por: Yamaguchi, Satoshi, et al.
Publicado: (2020)

Respiratory sarcopenia is a predictor of all‐cause mortality in community‐dwelling older adults—The Otassha Study
por: Kera, Takeshi, et al.
Publicado: (2023)

Reply to Letter to the Editor: Increased Prevalence of Breast and All-cause Cancer in Female Orthopaedic Surgeons
por: Chou, Loretta B., et al.
Publicado: (2023)

Comparison of mortality between peritoneal dialysis and hemodialysis in polycystic kidney disease
por: Fang, Xingxing, et al.
Publicado: (2019)

Trimethylamine N-Oxide and mortality in hemodialysis patients: like a mystery
por: Zhao, Yu, et al.
Publicado: (2021)

Lack of significant association between dyslipidemia and COVID-19 mortality
por: Yang, Haiyan, et al.
Publicado: (2021)

Hyperphosphatemia and its relationship with blood pressure, vasoconstriction, and endothelial cell dysfunction in hypertensive hemodialysis patients
por: Jung, Jinwoo, et al.
Publicado: (2022)

Association of trimethylamine N-Oxide with cardiovascular and all-cause mortality in hemodialysis patients
por: Zhang, Pan, et al.
Publicado: (2020)

Variability of Serum Phosphate in Incident Hemodialysis Patients: Association with All-Cause Mortality
por: ter Meulen, Karlien J., et al.
Publicado: (2023)

Relationship between serum uric acid and all-cause mortality in dialysis patients: like being in wonderland, disoriented
por: Zhao, Yu, et al.
Publicado: (2020)

Pulmonary hypertension in a hemodialysis porcine model: possible unforeseen causes?
por: Pethő, Ákos, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b4lg7rnrb8b5s96e3r8kbbrm09